Resources

Melanie Sulistio, MD, Curtis Carothers, MD, Mandeep Mange, BS, Mike Lujan, BS, Rene Ofiveros, MD, and Robert Chilton, DO PART 2: GLP 1 Agonist-based Therapies: How do they reduce cardiovascular risks in diabetic patients? (For Part 1, just click here.) GLP-1 Agonist-based Therapies Reduce Cardiovascular Risk Weight loss is critical …

Duo AutoShield™ Duo is a next generation, 5mm safety-engineered pen needle designed to protect healthcare workers from needlestick injuries and blood exposure. It is now available in the US from BD Medical. The AutoShield™ Duo is the only pen needle with front and back-end needle protection. The safety mechanisms activate …

Overweight kids have lower levels of vitamin D than their slimmer counterparts, regardless of season, sex, or race and ethnicity.…

Adhering to a strict, low-carbohydrate diet two days per week led to greater reductions in weight and insulin levels when compared with standard daily dieting.…

Patients’ activity in the sympathetic nervous system that controls the fight or flight response appears to predict how well they will do when trying to lose weight….

Performing short cycle sprints three times a week could be enough to prevent and possibly treat type 2 diabetes.…

A study by Buitrago-Lopez and colleagues found that daily chocolate consumption had a positive effect on cardiovascular risk factors.…

Both tight glycemic control and poor glycemic control are associated with worse outcomes in diabetes patients with chronic kidney disease.…

An accelerated decline in brain function is an important risk that needs to be examined further in relation to glycemic control in older people with long-standing diabetes.…

Use of a margarine fortified with n-3 fatty acids significantly reduced post-myocardial infarction ventricular arrhythmia-related events by 84% among diabetic patients….